Hybrids: a new paradigm to treat Alzheimer's disease

Molecular Diversity
Manjinder SinghOm Silakari

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative condition with several target proteins contributing to its etiology. With 35.6 million cases worldwide documented in 2011, AD constitutes a devastating health, political, economic, and social problem for all nations. The cases are expected to increase beyond 107 million in 2050; unless an advanced therapy having a capability to delay the disease progression is developed. The curative paradigm of one-compound one-target that has been followed so far has not reached the desired mark. The research focus moved towards single molecule targeting two or more pathogenic mechanisms involved in neuronal death. Over the last few years, medicinal chemists have been paying attention to the design and synthesis of the hybrid molecules that are comprised of two pharmacophores from well-established chemical scaffolds endowed with requisite biological activities in a single entity. The hybrid-based approach has grown to be a central point in the medicinal chemistry field. Various important pharmacophores used for AD have been combined with selected biologically active molecules to get homo- and heterodimers with improved efficacy with additional supplementary actions. This review summarize...Continue Reading

References

Jan 1, 1985·Annals of the New York Academy of Sciences·R T BartusC Flicker
Aug 19, 1994·Journal of Medicinal Chemistry·A VillalobosA A Nagel
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·J NäslundP Greengard
Jan 1, 1995·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·A AlzheimerF R Murtagh
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·N A Simonian, J T Coyle
Feb 1, 1997·Brain Research. Brain Research Reviews·G MünchP Riederer
Mar 3, 1999·Journal of Medicinal Chemistry·J M ContrerasC G Wermuth
Sep 7, 1999·Bioorganic & Medicinal Chemistry Letters·P R CarlierY P Pang
Sep 1, 2000·Brain Research. Brain Research Reviews·L BuéeP R Hof
Dec 21, 2000·European Journal of Medicinal Chemistry·A MartinezA Badia
Sep 21, 2001·Journal of Medicinal Chemistry·C Doucet-PersoneniT Lewis
Feb 6, 2002·Chembiochem : a European Journal of Chemical Biology·O Dechy-CabaretB Meunier
May 17, 2002·Journal of Medicinal Chemistry·Ming-Kuan HuMao-Hsiung Yen
Dec 25, 2002·Medicinal Research Reviews·Carlo MelchiorreVincenzo Tumiatti
Mar 20, 2003·Bioorganic & Medicinal Chemistry Letters·Katalin Prokai-TatraiLaszlo Prokai
Nov 11, 2003·The Journal of Pharmacy and Pharmacology·Vildan AlptüzünUlrike Holzgrabe
Nov 4, 2004·CNS Drugs·Beate SchmittLutz Frölich
Nov 17, 2004·Current Pharmaceutical Design·Maurizio Recanatini, Piero Valenti
Jan 5, 2005·Trends in Pharmacological Sciences·Moussa B H Youdim, Jerry J Buccafusco
Apr 28, 2005·Neuroscience Letters·Mi-Hyeon JangEe-Hwa Kim
Jun 25, 2005·Current Alzheimer Research·Nibaldo C InestrosaMarcela Colombres
Jun 28, 2005·Bioorganic & Medicinal Chemistry Letters·Sam Sik KangByung Hee Han
Jul 5, 2005·Bioorganic & Medicinal Chemistry Letters·Rong ShengYongzhou Hu

❮ Previous
Next ❯

Citations

Jan 9, 2017·European Journal of Medicinal Chemistry·Jakub JeřábekMaria Laura Bolognesi
Jan 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Olga KaroutzouMarta Barniol-Xicota
Apr 14, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Irini DoytchinovaIvan Dimitrov
Apr 14, 2018·Current Neuropharmacology·Maja PrzybyłowskaIwona Inkielewicz-Stepniak
Feb 2, 2019·Current Topics in Medicinal Chemistry·Mridula Saxena, Ragini Dubey
Sep 21, 2019·Mini Reviews in Medicinal Chemistry·Yaghoub PourshojaeiAli Asadipour
Aug 6, 2016·Molecular Informatics·Georgi StavrakovIrini Doytchinova
Jun 27, 2019·Current Topics in Medicinal Chemistry·Viktoriya IvasivMaria L Bolognesi
Jul 29, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Georgi StavrakovIrini Doytchinova
Apr 13, 2018·International Journal of Molecular Sciences·Anna PawełczykLucjusz Zaprutko
Mar 16, 2018·ACS Medicinal Chemistry Letters·Xue-Yang JiangHao-Peng Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.